This finding is consistent with recent observations that HMGB1 is highly expressed in BM mononuclear cells of AML patients, which affects the activity of the downstream gene TGFBI and the expression levels of TNF-α, IL-1β and SCF, blocking AML cell proliferation and myeloid cell differentiation [41–43]. This evidence concerns the gene TGFBI and acute myeloid leukemia.